Livzon Pharmaceutical Group Inc. (000513.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 30.78B |
| Enterprise Value | 25.32B |
| P/E Ratio | 17.83 |
| PEG Ratio | -0.66 |
| Price/Sales Ratio | 2.41 |
| Price/Book Ratio | 2.13 |
| Enterprise/Revenue | 2.11 |
| Enterprise/EBITDA | 9.22 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.15 |
| Operating Margin | 0.19 |
| Return On Assets | 0.07 |
| Return On Equity | 0.11 |
| Revenue | 11.91B |
| Revenue/Share | 11.51 |
| Gross Profit | 7.63B |
| EBITDA | 3.48B |
| Net Income | 2.02B |
| Diluted EPS | 2.27 |
| Total Cash | 7.32B |
| Total Cash/Share | 8.24 |
| Total Debt | 4.2B |
| Total Debt/Equity | 0.32 |
| Current Ratio | 1.48 |
| Book Value Per Share | 15.92 |
| 52-Week Change | -16.35 |
| 52-Week High | 37.85 |
| 52-Week Low | 25.7 |
| Moving Average 50 Days | 28.76 |
| Moving Average 200 Days | 31.23 |
| Average Volume | 11.61M |
| Shares Outstanding | 789.59M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 2.45 |
| Trailing Annual Dividend Yield | 7.85 |
| Payout Ratio | 1.01 |
| Last Split Factor | 13:10 |
| Last Split Date | July 03, 2019 |